Ayotte Tours Salem's Gamma Medica

Submitted on behalf of U.S Sen. Kelly Ayotte

Jim Calandra, president and CEO of Gamma Medica and the Gamma Medica team welcomed U.S Sen. Kelly Ayotte when she visited the Salem firm for a company tour and technology review on Friday.

Specializing in advanced digital molecular imaging technology, Gamma Medica’s product, the LumaGEM®  Molecular Breast Imaging (MBI) system clearly highlights tumors obscured by dense breast tissue enabling the early detection of breast cancer.

Approximately 40 percent of women have dense breast tissue which makes presently available mammography screening unlikely to identify early-stage cancers.

“Gamma Medica provides a leading-edge technology designed to aid breast radiologists in diagnosing difficult cases, particularly in women with dense breast tissue. We were pleased to have Senator Ayotte learn more about the advancement of medical technology that enables women with dense breast tissue to have timely and accurate information concerning their health,” stated Jim Calandra, president and CEO of Gamma Medica.

About Gamma Medica, Inc.

Gamma Medica recently moved to New Hampshire and is comprised of 26 employees with excellent imaging technology experience and expertise in the areas of research and development, product design and engineering, manufacturing, regulatory, sales and marketing and clinical trials.

www.gammamedica.com